Mesothelioma UK awards £38,000 grant for new research study into exercise therapy for asbestos-related cancer patients

Mesothelioma UK, the national asbestos-related cancer charity, has awarded a £38,301 grant for an 18-month research project to explore how exercise therapy can improve symptom control, fitness and the quality of life of mesothelioma patients.

The new project, titled ‘EXTRA-Meso feasibility study – EXercise TheRApy in Mesothelioma’, is a collaboration between researchers from the University of Glasgow, NHS Greater Glasgow & Clyde, Manchester University NHS Foundation Trust (MFT) and Greater Manchester Cancer Alliance.

The new study follows the successful Prehab4Cancer and Recovery programme, a free exercise, nutrition and wellbeing scheme in Greater Manchester. It was designed to help people with a recent diagnosis of cancer prepare for and cope better with their treatment.

For more information on the study or how to apply, patients can contact their Mesothelioma UK Clinical Nurse Specialist, email info@mesothelioma.uk.com or call  0800 169 2409 (freephone) from 9am to 4pm from Monday to Friday. Recruitment for the study will begin in summer 2023.

Dr Selina Tsim from the Institute of Cancer Sciences, University of Glasgow, NHS Greater Glasgow and Clyde, and Chief Investigator for the study said: “A ‘prehab’ exercise and nutrition programme has already proved successful in Greater Manchester and this new study will look at how a similar programme could positively impact the lives of mesothelioma patients. Dependent upon the results of the 18-month study, we hope to move to phase three and deliver a randomised controlled trial.”

Dr Matthew Evison, Consultant Chest Physician at Wythenshawe Hospital, part of Manchester University NHS Foundation Trust commented: “Prehabilitation has been shown to deliver highly meaningful benefits to patients with a number of different cancers as they prepare for, undergo and recover from treatment. It is very exciting to examine the impact that this intervention might have for patients with mesothelioma.”

Liz Darlison, Chief Executive of Mesothelioma UK added: “The Health and Safety Executive estimates that more than 5,000 people die from asbestos-related cancers each year so research into the deadly disease of mesothelioma is critical. Evidence from the previous lung cancer-related programme in Manchester indicates that this approach has had a positive impact on a number of patients and we’re excited to find out how this can help patients in the UK mesothelioma community.”

Published: 13 June 2023

June 13, 2023

Other News

Vital Support for Peritoneal Mesothelioma Patients

DaSH Global and Mesothelioma UK are delighted to announce the launch of an updated ‘Your Health Companion’ to support patients living with peritoneal mesothelioma within the UK and across the world. Your Health Companion is the first real-world data collection tool,...

<